Don’t Worry Americans, We’re Just Going Through You to Get to Him / Editorial Cartoon
http://www.gocomics.com/stevebenson/2013/09/08#.UqKtwmRDsrd
Steve Benson by Steve Benson
- September 08, 2013
- Previous feature
-

- Next feature
- Current
http://www.gocomics.com/stevebenson/2013/09/08#.UqKtwmRDsrd
“Bruce Ivins was a cold-blooded murderer, a deranged psycho-killer, who in the fall of 2001, cooked up a virulent batch of powdered anthrax, drove to Princeton, N.J., and mailed letters loaded with the lethal mix to five news organizations and two U.S. senators. At least, that’s what the FBI says. The letters infected 22 people,…
Without evidence and most likely in a deal with Pfizer, Israel vaccinated 250,000 citizens with a 4th dose of vaccine. These human guinea pigs have now learned this not only did not help them, but it may be impairing their immune response to COVID, making them more susceptible to infection. Last Monday Israel had 40,000…
How did Professor Haigwood come to make the case against Ivins? It appears that (like Jean Duley, Ivins’ trainee therapist who was under house arrest when she was brought by FBI to obtain a restraining order against Ivins, then was trotted out for all major media by the FBI before she went into hiding) Haigwood too received…
Pam Weintraub, editor of Discover Magazine, has an in-depth piece on problems with commonly used drugs on the ExperienceLife website. The acid blockers (proton pump inhibitors like Prilosec or Nexium), sold over-the-counter or by prescription, can cause a variety of problems from long-term use. Getting off them can be a challenge, because a hyperacidity…
I do not know how the CDC operates. But I have been watching Anne Schuchat for over 20 years, since she was chosen to provide CDC’s testimony to Congress about the anthrax vaccine. She is quick on her feet, she is a good liar, she is now the highest career official at CDC, and she…
From Niko Kyriakou at Truthout, excerpts: Wow, what a year 2009 was for makers of the swine flu vaccine. CSL Limited‘s profits rose 63 percent above 2008 levels, while in the third quarter of 2009 – just about the time H1N1 contracts picked up steam – GlaxoSmithKine enjoyed a 30 percent jump in earnings to…